Hypertriglyceridemia
📧 Sign up to get email alerts when something new happens for Hypertriglyceridemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-03-18Clinical Trial Update: Effect of Omega-3 Fatty Acids Supplementation on Hypertriglyceridemia in Pediatric Patients With Obesity. [NA]
Completed clinical trial evaluating omega-3 fatty acid supplementation for hypertriglyceridemia in pediatric obesity; results were posted on…
-
CLINICAL_TRIALS withdrawal · 2025-03-03Clinical Trial Update: Effect of Extraneal (Icodextrin)on Triglyceride Levels in PD Patients [Phase 4]
Phase 4 trial evaluating Extraneal (icodextrin) and triglyceride levels in peritoneal dialysis patients was withdrawn.
-
FDA approval · 2024-12-19FDA Approved: TRYNGOLZA — Original Application (Ionis Pharmaceuticals, Inc.)
FDA approves TRYNGOLZA (olesarsen sodium) from Ionis Pharmaceuticals as a new molecular entity for the treatment of severe hypertriglyceride…
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: Impacts of Lentils on Metabolism and Inflammation [NA]
Completed clinical trial evaluating the effects of lentil consumption on metabolism and inflammation; results have been posted. Sponsor: Mon…
-
FDA approval · 2024-11-20FDA Approved: ICOSAPENT ETHYL — Original Application (Qilu Pharmaceutical Co., Ltd.)
The FDA approved ICOSAPENT ETHYL from Qilu Pharmaceutical Co., Ltd. via an original application (ANDA218899).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-11-13FDA Approved: FENOFIBRATE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods Pharmaceuticals Limited's fenofibrate as an Original Application generic (ANDA 210248). This marks the approval of a g…
-
FDA approval · 2024-08-22FDA Approved: FENOFIBRATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for fenofibrate submitted by Aurobindo Pharma Limited, relating to a generic fenofibrate product.
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia (0653-036)(COMPLETED) [Phase 3]
A Phase 3 study evaluating the combination of ezetimibe and fenofibrate in patients with mixed hyperlipidemia has completed.
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036) [Phase 3]
Phase 3 trial evaluating two investigational drugs for mixed hyperlipidemia has completed.
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED) [Phase 3]
A Phase 3 clinical trial evaluating an investigational drug (0653A-071) for mixed hyperlipidemia has completed; the study enrolled patients …
-
CLINICAL_TRIALS research · 2024-08-15Clinical Trial Update: Exploring Physical Exercise for the Regulation and Control of Metabolic Disorders in College Students. [NA]
This clinical trial explores the effects of physical exercise on regulating metabolic disorders in college students; recruitment has not yet…
-
FDA approval · 2024-07-30FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for Fenofibrate.
-
CLINICAL_TRIALS trial_result · 2024-07-25Clinical Trial Update: Study to Explore the Efficacy and Safety of BIO89-100 (Pegozafermin) in Participants With Severe Hypertriglyceridemia [Phase 2]
Phase 2 trial evaluating safety and efficacy of BIO89-100 (pegozafermin) in adults with severe hypertriglyceridemia has completed and result…
-
CLINICAL_TRIALS trial_result · 2024-07-15Clinical Trial Update: Efficacy of Ethyl Icosapentate in Patients With Severe Hypertriglyceridemia [Phase 3]
A Phase 3 trial evaluating the efficacy of Ethyl Icosapentate in adults with severe hypertriglyceridemia has completed.
-
CLINICAL_TRIALS research · 2024-05-24Clinical Trial Update: Effects of Phytoestrogen From Pueraria Mirifica in Improvement of Serum Lipid Parameters in Postmenopausal Women [Phase 2, Phase 3]
A clinical trial is evaluating a phytoestrogen extract from Pueraria mirifica for improving serum lipid parameters in postmenopausal women, …
-
CLINICAL_TRIALS trial_result · 2024-05-22Clinical Trial Update: Efficacy and Safety of Evinacumab in Adult Patients With Severe Hypertriglyceridemia for the Prevention of Recurrent Acute Pancreatitis [Phase 2]
Phase 2 study of evinacumab in adults with severe hypertriglyceridemia for prevention of recurrent acute pancreatitis has been terminated; r…
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: Effects of Replacing Energy From Solid Fats and Added Sugars (SoFAS) With Avocado [NA]
A completed clinical trial evaluating whether replacing solid fats and added sugars with avocado affects triglyceride levels in people with …
-
FDA approval · 2024-05-17FDA Approved: GEMFIBROZIL — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for Gemfibrozil submitted by Chartwell RX, LLC.
-
CLINICAL_TRIALS trial_result · 2024-04-02Clinical Trial Update: The Use of Icosapent Ethyl on Vascular Progenitor Cells in Individuals With Elevated Cardiovascular Risk [Phase 4]
A Phase 4 clinical trial evaluated the effect of icosapent ethyl on vascular progenitor cells in individuals with elevated cardiovascular ri…
-
FDA approval · 2024-02-16FDA Approved: ICOSAPENT ETHYL — Original Application (Northstar Rx LLC)
FDA approved the original application for icospent ethyl (ICOSAPENT ETHYL) from Northstar Rx LLC, a generic version of the prescription ther…
-
CLINICAL_TRIALS trial_result · 2024-02-14Clinical Trial Update: AlmegaPL CV Health Open Label Study [Phase 4]
Open-label Phase 4 trial of AlmegaPL for cardiovascular health completed; study focused on cholesterol and triglycerides management.
-
FDA approval · 2024-02-08FDA Approved: FENOFIBRIC ACID — Original Application (Macleods Pharmaceuticals Limited)
FDA approved an original application for fenofibric acid (generic) manufactured by Macleods Pharmaceuticals Limited.
-
FDA approval · 2024-02-01FDA Approved: GEMFIBROZIL — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for gemfibrozil by Chartwell RX, LLC.
-
FDA approval · 2024-01-31FDA Approved: FENOFIBRATE — Original Application (Chartwell RX, LLC.)
FDA approved fenofibrate (generic) under Original Application ANDA211407 for Chartwell RX, LLC. This marks the approval of a first generic v…
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Evaluation of Safety and Effects of SLx-4090 After Dosing for 14 Days in Subjects With High Triglycerides [Phase 2]
Phase 2 trial evaluating safety and effects of SLx-4090 after 14 days of dosing in subjects with high triglycerides has completed.